Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 599

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 599
---
 ​      | ​                
 Per Share        
 Estimated Fair   
 Value of Options |    ​ |
|:-----------------|:--|------------------:|:--|:---------------|-----:|:--|:--------------|-----:|:-------|:-----------------|-----:|
| January 12, 2023 |   |           607,129 | ​ | $              | 0.82 | ​ | $             | 0.82 | ​      | $                | 0.52 |
| June 27, 2023    |   |            60,000 | ​ | $              | 0.82 | ​ | $             | 0.82 | (1)  ​ | $                | 0.52 |
| June 27, 2023    |   |            20,000 | ​ | $              | 0.82 | ​ | $             | 0.82 | (1)  ​ | $                | 0.53 |
| January 31, 2024 |   |            25,000 | ​ | $              | 0.92 | ​ | $             | 0.92 | ​      | $                | 0.62 |

| (1) | At the time of the options grants on June 27, 2023, Tvardi’s board of directors determined that the fair value of its common stock of $0.82 per share, calculated by its third-party valuation as of June 30, 2022, reasonably reflected the per share fair value of its common stock as of the grant date. Tvardi applied the fair value of common stock from its retrospective fair value assessment to determine the fair value of the June 27, 2023 awards, noting an immaterial incremental stock-based compensation expense to be recorded for accounting purposes of approximately $2,000. |

Recently Issued and Adopted Accounting Pronouncements A description of recently issued accounting pronouncements that may potentially impact Tvardi’s financial position and results of operations is disclosed in Note 2 to the unaudited condensed financial statements for the nine months ended September 30, 2024 and 2023 and in Note 2 to the financial statements for the years ended December 31, 2023 and 2022, included elsewhere in this proxy statement/prospectus.

328

Quantitative and Qualitative Disclosures About Market Risks

Interest Rate Risk

As of September 30,